{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:19:32Z","timestamp":1765545572269},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,8,14]],"date-time":"2009-08-14T00:00:00Z","timestamp":1250208000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s12032-009-9287-8","type":"journal-article","created":{"date-parts":[[2009,8,13]],"date-time":"2009-08-13T15:04:06Z","timestamp":1250175846000},"page":"791-797","source":"Crossref","is-referenced-by-count":14,"title":["Aberrant methylation profile of 14-3-3 sigma and its reduced transcription\/expression levels in Chinese sporadic female breast carcinogenesis"],"prefix":"10.1007","volume":"27","author":[{"given":"Jie","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuanbin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,14]]},"reference":[{"key":"9287_CR1","first-page":"999","volume-title":"The metabolic and molecular basis of human disease","author":"FJ Couch","year":"2001","unstructured":"Couch FJ, Weber BL. Breast cancer. In: Scriver CR, Beaudet AL, Sly WS, editors. The metabolic and molecular basis of human disease. New York: McGraw-Hill; 2001. p. 999\u20131031."},{"key":"9287_CR2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1055-3207(18)30181-9","volume":"8","author":"AM Leitch","year":"1999","unstructured":"Leitch AM. Breast cancer screening: success amid conflict. Surg Oncol Clin N Am. 1999;8:657\u201372.","journal-title":"Surg Oncol Clin N Am"},{"key":"9287_CR3","doi-asserted-by":"crossref","first-page":"23106","DOI":"10.1074\/jbc.M905616199","volume":"275","author":"K Tomoshige","year":"2000","unstructured":"Tomoshige K, Alexander G, Antonio V, et al. Vpr protein of human immunodeficiency virus type 1 binds to 14\u20133-3 proteins and facilitates complex formation with Cdc25C: implications for cell cycle arrest. J Biol Chem. 2000;275:23106\u201312.","journal-title":"J Biol Chem"},{"issue":"1","key":"9287_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1097-2765(00)80002-7","volume":"1","author":"H Hermeking","year":"1997","unstructured":"Hermeking H, Lengauer C, Polyak K, et al. 14\u20133-3\u00a0sigma is a p53-regulated inhibitor of G2\/M progression. Mol Cell. 1997;1(1):3\u201311.","journal-title":"Mol Cell"},{"issue":"6753","key":"9287_CR5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/44029","volume":"401","author":"TA Chan","year":"1999","unstructured":"Chan TA, Hermeking H, Lengauer C, et al. 14-3-3 sigma is required to prevent mitotic catastrophe after DNA damage. Nature. 1999;401(6753):535\u20137.","journal-title":"Nature"},{"key":"9287_CR6","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/1521-1878(200008)22:8<728::AID-BIES6>3.0.CO;2-B","volume":"22","author":"CX Deng","year":"2000","unstructured":"Deng CX, Brodie SG. Role of BRCA1 and its interacting protein. Bioessays. 2000;22:728\u201337.","journal-title":"Bioessays"},{"key":"9287_CR7","volume-title":"Molecular cloning. A laboratory manual","author":"J Sambrook","year":"2001","unstructured":"Sambrook J, Russell DW. Molecular cloning. A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2001."},{"key":"9287_CR8","doi-asserted-by":"crossref","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","volume":"58","author":"JG Herman","year":"1996","unstructured":"Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acid Sci USA. 1996;58:9821\u20136.","journal-title":"Proc Natl Acid Sci USA"},{"key":"9287_CR9","first-page":"442","volume":"25","author":"J Feng","year":"2005","unstructured":"Feng J, Zhang JC, Tao JS, et al. Hypermethylation detection of BRCA1 gene promoter in plasm of sporadic breast cancer patients. China Oncol. 2005;25:442\u20135.","journal-title":"China Oncol"},{"key":"9287_CR10","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1073\/pnas.100566997","volume":"97","author":"AT Ferguson","year":"2000","unstructured":"Ferguson AT, Evron E, Umbricht CB, et al. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. PNAS. 2000;97:6049\u201354.","journal-title":"PNAS"},{"issue":"5","key":"9287_CR11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1369\/jhc.4A6544.2005","volume":"53","author":"F Al-Mulla","year":"2005","unstructured":"Al-Mulla F, Abdulrahman M, Varadharaj G. BRCA1 gene expression in breast cancer: a correlative study between real-time RT-PCR and immunohistochemistry. J Histochem Cytochem. 2005;53(5):621\u20139.","journal-title":"J Histochem Cytochem"},{"key":"9287_CR12","first-page":"3097","volume":"66","author":"Y Huiling","year":"2006","unstructured":"Huiling Y, Yu-Ye W, Ruiying Z, et al. DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B\/Akt activation and suppresses Akt-activated cancer. Cancer Res. 2006;66:3097\u2013105.","journal-title":"Cancer Res"},{"key":"9287_CR13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1089\/dna.2005.24.264","volume":"24","author":"R Henrique","year":"2005","unstructured":"Henrique R, Carmen J, Mohammad OH, et al. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions. DNA Cell Biol. 2005;24:264\u20139.","journal-title":"DNA Cell Biol"},{"key":"9287_CR14","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1038\/sj.onc.1204438","volume":"20","author":"CB Umbricht","year":"2001","unstructured":"Umbricht CB, Evron E, Gabrielson E, et al. Hypermethylation of 14-3-3 s (stratifin) is an early event in breast cancer. Oncogene. 2001;20:3348\u201353.","journal-title":"Oncogene"},{"key":"9287_CR15","first-page":"165","volume":"12","author":"B Kishor","year":"2003","unstructured":"Kishor B, Abdul KS, Hussain A, et al. The tumor suppressor gene 14-3-3 sigma is commonly methylated in normal and malignant lymphoid cells. Cancer Epidemiol Biomarkers Prev. 2003;12:165\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9287_CR16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/sj.cr.7290292","volume":"15","author":"L Dmitri","year":"2005","unstructured":"Dmitri L, Heiko H. The role of epigenetic inactivation of 14-3-3 sigma in human cancer. Cell Res. 2005;15:237\u201346.","journal-title":"Cell Res"},{"key":"9287_CR17","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/44188","volume":"401","author":"TA Chan","year":"1999","unstructured":"Chan TA, Hermeking H, Langauer C, et al. 14-3-3 sigma is required to prevent mitotic catastrophe after DNA damage. Nature. 1999;401:616\u201320.","journal-title":"Nature"},{"key":"9287_CR18","first-page":"954","volume":"24","author":"TB Morrison","year":"1998","unstructured":"Morrison TB, Weis JJ, Wittwer CT. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques. 1998;24:954\u201362.","journal-title":"Biotechniques"},{"key":"9287_CR19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1074\/mcp.M400205-MCP200","volume":"4","author":"JM Moreira","year":"2005","unstructured":"Moreira JM, Ohlsson G, Rank FE, Celis JE. Down-regulation of the tumor suppressor protein 14-3-3 is a sporadic event in cancer of the breast. Mol Cell Proteomics. 2005;4:555\u201369.","journal-title":"Mol Cell Proteomics"},{"key":"9287_CR20","first-page":"9","volume":"40","author":"ES Dong","year":"2006","unstructured":"Dong ES, Jang SJ, Kim JS, et al. Expression of the 14-3-3 sigma protein and methylation status of the 14-3-3 sigma gene in biliary neoplasms. Korean J Pathol. 2006;40:9\u201316.","journal-title":"Korean J Pathol"},{"key":"9287_CR21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0002-9440(10)64880-8","volume":"160","author":"L Ulrich","year":"2002","unstructured":"Ulrich L, Florian L, Henning F, et al. Quantitative assessment of promoter hypermethylation during breast cancer development. Am J Pathol. 2002;160:605\u201312.","journal-title":"Am J Pathol"},{"key":"9287_CR22","doi-asserted-by":"crossref","first-page":"9105","DOI":"10.1200\/JCO.2005.02.2905","volume":"23","author":"JL Ramirez","year":"2005","unstructured":"Ramirez JL, Rafael R, Taron M, et al. 14-3-3 sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non\u2013small-cell lung cancer patients predicts survival: the spanish lung cancer group. J Clin Oncol. 2005;23:9105\u201312.","journal-title":"J Clin Oncol"},{"key":"9287_CR23","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1038\/sj.onc.1203898","volume":"19","author":"I Norikazu","year":"2000","unstructured":"Norikazu I, Hiroyuki Y, Shigeru S, et al. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Oncogene. 2000;19:5298\u2013302.","journal-title":"Oncogene"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9287-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-009-9287-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9287-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:22:40Z","timestamp":1559442160000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-009-9287-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,14]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["9287"],"URL":"https:\/\/doi.org\/10.1007\/s12032-009-9287-8","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,14]]}}}